相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:17Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.
Journal of clinical immunology·2023
Same author
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.
Thorax·2023
Same author
Imaging Features of Autoimmune Disease-Related Interstitial Lung Diseases.
Journal of thoracic imaging·2023
异性肺部疾病 异性肺部疾病
1National Coordinating Reference Center for rare pulmonary diseases, Department of Respiratory Medicine, Louis Pradel Hospital, Hospices Civils de Lyon, ERN-LUNG, INRAE, UMR754, Lyon 1 University, 28 avenue Doyen Lépine, Lyon F-69677, France.
Clinics in chest medicine
|October 19, 2025
概括
诊断eosinophilic肺部疾病涉及临床和成像发现,而不是典型的活检. 治疗重点在于识别和消除病因,除了葡萄皮质类药物和较新的介质蛋白-5疗法.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 生性肺部疾病 (ELDs) 是一组疾病,其特点是生细胞在肺组织中积累.
- 诊断往往依赖于临床表现,成像和膜性叶绿素友爱症的证据,而活检通常是为复杂病例保留的.
研究的目的:
- 概述了对eosinophilic肺部疾病的诊断方法.
- 讨论确定ELDs的病因学的影响.
- 审查目前和新兴的ELD治疗策略.
主要方法:
- 对诊断的临床成像特征的审查.
- 排除了已知的埃索诺菲利亚原因,包括药物和感染.
- 评估对葡萄糖皮质体和向疗法的治疗反应.
主要成果:
- 肺活检通常不需要诊断ELDs.
- 鉴定原因 (例如,药物,感染,吸烟) 对于有效的管理至关重要.
- 在排除所有其他潜在原因后,才诊断出异常病例.
结论:
- 有效的ELD管理包括解决潜在的病因和使用抗炎治疗.
- 口服葡萄糖皮质类药物仍然是主要治疗方法,越来越多地使用互白素-5轴抑制剂.
更多相关视频
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
6.5K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K